Low testosterone and heart health are connected in ways that are important for men to understand. Testosterone levels can be influenced by age, obesity, metabolic health, diabetes, sleep disorders, chronic illness, medications, and other factors that may also affect cardiovascular risk.
Research has found associations between low testosterone levels and several cardiovascular and metabolic conditions. However, an association does not necessarily mean that low testosterone directly causes heart disease. In some men, a low testosterone level may instead occur alongside underlying health problems that independently increase cardiovascular risk.
For this reason, evaluating testosterone should involve more than simply looking at a laboratory number. Symptoms, repeat hormone measurements when appropriate, cardiovascular and metabolic risk factors, medications, lifestyle, and the man’s overall health should all be considered before deciding whether treatment is indicated.
How Low Testosterone and Heart Health Are Connected
Testosterone interacts with several systems involved in cardiovascular and metabolic health. Men with low testosterone are more likely to have conditions such as obesity, insulin resistance, type 2 diabetes, metabolic syndrome, and reduced muscle mass. Many of these conditions are themselves established cardiovascular risk factors.
The relationship is complex and can work in more than one direction. For example, excess visceral fat and metabolic dysfunction can contribute to lower testosterone levels, while chronic illness and certain medications can suppress normal hormone production. As a result, low testosterone may sometimes function as a marker of broader health problems rather than as an isolated hormonal disorder.
Cardiovascular risk therefore should not be determined from a testosterone level alone. A comprehensive evaluation considers blood pressure, cholesterol, glucose metabolism, body composition, smoking, physical activity, sleep, family history, existing cardiovascular disease, and other relevant factors alongside a man’s hormonal symptoms and laboratory findings.
Does Low Testosterone Increase the Risk of Heart Disease?
Observational studies have found that men with lower testosterone levels often have higher rates of cardiovascular disease and cardiovascular risk factors. However, these findings do not prove that low testosterone itself causes heart disease. Age, obesity, diabetes, chronic illness, reduced physical activity, and other factors can influence both testosterone levels and cardiovascular risk.
This distinction is clinically important. A low testosterone result should not automatically be interpreted as a cardiovascular diagnosis, nor should testosterone treatment be viewed as a therapy for preventing heart disease. Instead, low testosterone—particularly when accompanied by symptoms—can provide an opportunity to evaluate the man’s broader metabolic and cardiovascular health.
The appropriate question is therefore not simply whether testosterone is “good” or “bad” for the heart. The more useful approach is to determine why testosterone is low, whether true testosterone deficiency is present, what other cardiovascular risk factors exist, and whether treatment is medically appropriate for the individual patient.
Obesity, Diabetes, and Metabolic Health
Obesity, insulin resistance, and type 2 diabetes are particularly important when considering testosterone and cardiovascular health. Men with excess visceral fat frequently have lower testosterone levels, while obesity is independently associated with hypertension, abnormal cholesterol, diabetes, sleep apnea, and cardiovascular disease.
This relationship can become cyclical. Increased body fat may contribute to hormonal changes and lower testosterone, while reduced muscle mass, fatigue, and decreased physical activity can make maintaining a healthy body composition more difficult. Insulin resistance and chronic metabolic dysfunction can further complicate the picture.
For this reason, identifying low testosterone should sometimes prompt a broader assessment of metabolic health. Depending on the individual, this may include evaluating body composition, blood pressure, fasting glucose or HbA1c, lipid levels, sleep quality, physical activity, nutrition, and other cardiovascular risk factors.
Addressing obesity and metabolic dysfunction remains important regardless of whether testosterone therapy is ultimately recommended. Improvements in nutrition, physical activity, sleep, weight management, and control of diabetes or other metabolic conditions can support both cardiovascular health and overall hormonal health.
Low Testosterone, Muscle Mass, and Cardiovascular Fitness
Testosterone plays an important role in maintaining muscle mass, strength, bone health, and body composition. Men with testosterone deficiency may experience reduced lean muscle mass, increased body fat, lower energy, or diminished exercise capacity, although these symptoms can also result from many other medical and lifestyle factors.
Maintaining skeletal muscle becomes increasingly important as men age. Muscle supports glucose metabolism, physical function, mobility, and the ability to remain physically active—all factors that can influence long-term cardiovascular and metabolic health.
Low testosterone should not be assumed to be the cause of poor cardiovascular fitness. However, when hormonal symptoms occur together with declining muscle mass, increasing abdominal fat, reduced activity, or metabolic abnormalities, evaluating these issues together can provide a more complete picture of a man’s health.
Resistance training, aerobic exercise, adequate protein intake, healthy nutrition, appropriate weight management, and treatment of underlying medical conditions remain important components of maintaining muscle and cardiovascular health, whether or not testosterone therapy is indicated.
How Should Low Testosterone Be Diagnosed?
Testosterone deficiency should not be diagnosed from symptoms alone or from a single low laboratory result. Symptoms such as fatigue, reduced libido, erectile difficulties, decreased muscle mass, mood changes, and increased body fat can have many possible causes.
Current clinical guidelines generally recommend diagnosing testosterone deficiency only when a man has compatible symptoms or signs together with consistently low testosterone levels. Because testosterone levels vary during the day and can be affected by illness, sleep, nutrition, medications, and other factors, testing is typically performed using morning testosterone measurements and may need to be repeated to confirm the finding.
Depending on the clinical situation, additional laboratory evaluation may help determine why testosterone is low. This can include assessment of luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, and other tests when clinically indicated. The physician should also review medications, obesity, sleep disorders, chronic illnesses, and other potentially reversible contributors.
A proper diagnosis matters because testosterone therapy should be directed toward appropriately evaluated men with testosterone deficiency—not simply toward increasing a laboratory value.
Is Testosterone Therapy Safe for the Heart?
The cardiovascular safety of testosterone therapy has been studied extensively, but the answer requires appropriate context. Testosterone therapy is not a treatment for preventing heart attacks or cardiovascular disease, and it should not be prescribed solely for cardiovascular protection.
Large randomized clinical trial data have provided important reassurance for appropriately selected men with confirmed testosterone deficiency. In the TRAVERSE trial, testosterone replacement therapy was not associated with a higher rate of major adverse cardiovascular events than placebo among men with symptomatic hypogonadism who had preexisting cardiovascular disease or an increased cardiovascular risk.
However, cardiovascular safety does not mean testosterone therapy is appropriate for every man. Treatment requires proper diagnosis, assessment of contraindications and individual risk factors, appropriate dosing, and ongoing monitoring. The TRAVERSE trial also reported higher incidences of certain adverse events in the testosterone group, including atrial fibrillation, acute kidney injury, and pulmonary embolism, emphasizing the importance of individualized medical supervision.
Decisions about testosterone therapy should therefore be based on confirmed testosterone deficiency, symptoms, the patient’s overall health, potential benefits and risks, and shared decision-making—not on the assumption that raising testosterone will improve cardiovascular outcomes.
What Should Be Checked Before Starting Testosterone Therapy?
Before testosterone therapy is started, the physician should confirm that the patient has both appropriate symptoms and consistently low testosterone levels. The evaluation should also consider why testosterone is low and whether potentially reversible factors—such as obesity, sleep disorders, medications, acute or chronic illness, or metabolic dysfunction—may be contributing.
Cardiovascular risk factors should be reviewed as part of the broader health assessment. Blood pressure, lipid levels, glucose or HbA1c, smoking history, body composition, physical activity, and known cardiovascular disease may all be relevant depending on the individual patient.
Baseline testing and clinical assessment may also include hemoglobin and hematocrit because testosterone can increase red blood cell production. Prostate health, fertility goals, sleep apnea, urinary symptoms, and other potential contraindications or precautions should be considered when appropriate.
Men who are planning future fertility require particular attention because exogenous testosterone can suppress sperm production. Testosterone therapy therefore should not be approached as a routine anti-aging treatment or prescribed solely because a laboratory value falls near the lower end of a reference range.
Monitoring Testosterone Therapy and Cardiovascular Health
Testosterone therapy requires ongoing monitoring rather than a prescription followed by indefinite treatment without reassessment. Follow-up allows the physician to determine whether symptoms are improving, testosterone levels are within an appropriate range, and treatment is producing any clinically important adverse effects.
Hemoglobin and hematocrit should be monitored because testosterone therapy can increase red blood cell production. Excessive elevation of hematocrit can increase blood viscosity and may require adjustment or interruption of treatment and evaluation for contributing factors.
Follow-up should also consider blood pressure, cardiovascular symptoms, metabolic health, prostate-related monitoring when appropriate, sleep apnea, medication changes, and the patient’s overall response to treatment. New chest discomfort, unexplained shortness of breath, palpitations, leg swelling, or other concerning symptoms warrant appropriate medical evaluation rather than simply adjusting testosterone dosage.
The goal of treatment is not to achieve the highest possible testosterone level. It is to improve clinically relevant symptoms in appropriately diagnosed men while maintaining safe, physiologic treatment and monitoring the patient’s broader health.
Improving Low Testosterone and Heart Health Together
Improving hormonal and cardiovascular health often involves addressing many of the same modifiable factors. Regular physical activity, resistance training, maintaining a healthy body weight, nutritious food choices, adequate sleep, avoiding tobacco, and appropriate management of blood pressure, cholesterol, and blood glucose can support overall metabolic and cardiovascular health.
For men with obesity or metabolic dysfunction, meaningful weight loss may also improve testosterone levels in some cases. Likewise, identifying and treating conditions such as obstructive sleep apnea, diabetes, and other chronic illnesses may address factors contributing to both hormonal symptoms and cardiovascular risk.
These measures are important whether or not testosterone therapy is ultimately recommended. Testosterone replacement should complement—not replace—appropriate management of cardiovascular and metabolic risk factors when treatment is medically indicated.
Understanding low testosterone and heart health as interconnected parts of a man’s overall health allows treatment decisions to focus on more than a hormone number. The objective is to address symptoms, identify underlying health problems, reduce modifiable risk factors, and support long-term health.
The Bottom Line: Testosterone Is Only One Part of Men’s Cardiovascular Health
Low testosterone can occur alongside obesity, diabetes, metabolic dysfunction, sleep disorders, chronic illness, and other conditions that also influence cardiovascular health. For that reason, a low testosterone result should be viewed within the context of the man’s overall health rather than as an isolated laboratory finding.
The relationship between low testosterone and heart health is complex. Current evidence does not support using testosterone therapy as a treatment to prevent cardiovascular disease. At the same time, appropriately prescribed testosterone therapy can be considered for men with confirmed testosterone deficiency after an individualized evaluation of potential benefits, risks, and treatment goals.
At Concierge Men’s Wellness, our physician-led approach evaluates hormonal symptoms together with cardiovascular, metabolic, sexual, and lifestyle factors. When testosterone therapy is appropriate, treatment should include appropriate monitoring and ongoing reassessment rather than focusing solely on achieving a particular testosterone number.
Men experiencing persistent symptoms of testosterone deficiency should consider a comprehensive medical evaluation to identify possible causes, assess relevant health risks, and determine whether treatment is appropriate.